SaludBUENO

Treatment

Semaglutide Injectable

A weekly compounded semaglutide injection, with evaluation and follow-up from a licensed provider.

From $269/mo

Semaglutide Injectable

How this treatment works

Semaglutide is a GLP-1 receptor agonist that helps regulate appetite, reduce cravings, and extend the feeling of fullness. It is given once a week as a subcutaneous injection. Your provider raises the dose gradually to reduce side effects during the first weeks.

What's included

  • Medical evaluation with a US-licensed provider
  • A treatment plan personalized to your health history
  • Medication shipped to your home in discreet packaging
  • Syringes, needles, and an injection kit
  • Medical follow-up throughout the program
  • The full PesoBUENO program, at no additional cost

Side effects and considerations

  • Nausea, especially when starting or increasing the dose
  • Constipation or diarrhea
  • Mild fatigue during the first weeks
  • Occasional reflux or stomach discomfort

This list is not exhaustive. Your doctor will review your full medical history during the evaluation.

Questions about this treatment

Treatment subject to medical review. Available only for adults 18+ in states where telehealth is permitted for this medication.

SaludBUENO

  • SaludBUENO guarantee
  • Free, fast shipping
  • Doctor-led plans & follow-up
  • No hidden fees

The evaluation available on the SaludBUENO website does not by itself establish a provider-patient relationship between the person completing it and SaludBUENO. CareValidate, a network of U.S.-licensed providers that follows protocols designed for patient safety, sets exclusionary criteria to determine whether a person does not qualify for GLPs treatments. The answers you submit determine whether your case is eligible for review. If you qualify, a licensed provider will review your case before any prescription.

All claims and benefits described on this site are based on experiences reported by patients enrolled in programs that include compounded medications and consultations with health professionals. Results may vary and depend on multiple factors, including program adherence and the treating provider's recommendations.

Compounded GLP medications are produced in FDA-regulated 503A pharmacies. Although these facilities are highly regulated, compounded medications are not FDA-approved or evaluated for safety, efficacy, or quality. The decision to use compounded medications is based on the licensed provider's clinical judgment, taking into account the telehealth consultation and the patient's medical history.

We encourage anyone interested in compounded medications to consult with a health professional about the specific risks and benefits. SaludBUENO does not produce compounded medications. The product received may look different from the images shown on this site.